Report on the Use of Previously Raised Funds

Report on the Use of Previously Raised Funds

Qingdao Yingpais Health Technology Co., Ltd. (hereinafter referred to as "Yingpais" or "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions. In accordance with the relevant provisions of the "Guidelines for the Application of Regulatory Rules - Issuance No. 7" issued by the China Securities Regulatory Commission, the Board of Directors of Qingdao Yingpais Health Technology Co., Ltd. hereby reports on the use of previously raised funds as of December 31, 2025:

1. Basic Information on Previously Raised Funds

(1) Actual Amount of Funds Raised and Time of Receipt

With the approval of the China Securities Regulatory Commission regarding the registration of the issuance of shares to specific objects (Zheng Jian Xu Ke [2023] No. 1168), the Company issued 27,796,976 ordinary shares (A shares) at a par value of RMB 1 per share, with an issuance price of RMB 13.89 per share, raising a total of RMB 386,099,996.64. After deducting various issuance expenses (excluding tax) of RMB 6,441,317.90, the net amount raised was RMB 379,658,678.74. He Xin Accounting Firm (Special General Partnership) conducted an audit of the above-mentioned funds received on April 12, 2024, and issued the "Verification Report on the Funds Raised by Qingdao Yingpais Health Technology Co., Ltd. for Issuing Shares to Specific Objects" (He Xin Yan Zi [2024] No. 000011). The Company has opened a special account to store the above-mentioned raised funds.

(2) Status of Funds in the Special Account

As of December 31, 2025, the status of the funds raised in the special account for the issuance of shares to specific objects in 2022 is as follows: